留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

再次肾移植技术操作规范(2019版)

中华医学会器官移植学分会

中华医学会器官移植学分会. 再次肾移植技术操作规范(2019版)[J]. 器官移植, 2019, 10(5): 547-551. doi: 10.3969/j.issn.1674-7445.2019.05.014
引用本文: 中华医学会器官移植学分会. 再次肾移植技术操作规范(2019版)[J]. 器官移植, 2019, 10(5): 547-551. doi: 10.3969/j.issn.1674-7445.2019.05.014
Branch of Organ Transplantation of Chinese Medical Association. Technical operation specification for renal retransplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 547-551. doi: 10.3969/j.issn.1674-7445.2019.05.014
Citation: Branch of Organ Transplantation of Chinese Medical Association. Technical operation specification for renal retransplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 547-551. doi: 10.3969/j.issn.1674-7445.2019.05.014

再次肾移植技术操作规范(2019版)

doi: 10.3969/j.issn.1674-7445.2019.05.014
基金项目: 

国家自然科学基金 81570680

国家自然科学基金 81571555

详细信息
    通讯作者:

    张伟杰,1967年生,博士,教授,主任医师,研究方向为肾移植临床与基础研究,Email:wjzhangtj@126.com

  • 中图分类号: R617, R619

Technical operation specification for renal retransplantation (2019 edition)

  • 摘要: 为了进一步规范再次肾移植的技术操作,中华医学会器官移植学分会组织器官移植学专家从再次肾移植的适应证,移植肾切除,手术时机的选择,供、受者的免疫学选择,手术方法,术后免疫抑制方案的选择及供体特异性抗体(DSA)的监测等方面,制订本规范。

     

  • [1] MAGEE JC, BARR ML, BASADONNA GP, et al. Repeat organ transplantation in the United States, 1996-2005[J]. Am J Transplant, 2007, 7(5 Pt 2):1424-1433. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=8aec196bd4879f446141d0b3681ef5b5
    [2] 夏穗生, 于立新, 夏求明, 等.器官移植学[M].上海:上海科学技术出版社, 2009:674.
    [3] ALBANO L, BRETAGNE S, MAMZER-BRUNEEL MF, et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France[J]. Clin Infect Dis, 2009, 48(2):194-202. DOI: 10.1086/595688.
    [4] KASISKE BL, SNYDER JJ, GILBERTSON DT, et al. Cancer after kidney transplantation in the United States[J]. Am J Transplant, 2004, 4(6):905-913. doi: 10.1111/j.1600-6143.2004.00450.x
    [5] HEAPHY EL, POGGIO ED, FLECHNER SM, et al. Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant[J]. Am J Transplant, 2014, 14(6):1356-1367. DOI: 10.1111/ajt.12690.
    [6] GRALLA J, TONG S, WISEMAN AC. The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients[J]. Transplantation, 2013, 95(10):1218-1224. DOI: 10.1097/TP.0b013e318288ca14.
    [7] ZHU L, FU C, LIN K, et al. Patterns of early rejection in renal retransplantation: a single-center experience[J]. J Immunol Res, 2016:2697860. DOI: 10.1155/2016/2697860.
    [8] LIN J, WANG R, XU Y, et al. Impact of renal allograft nephrectomy on graft and patient survival following retransplantation: a systematic review and Meta-analysis[J]. Nephrol Dial Transplant, 2018, 33(4):700-708. DOI: 10.1093/ndt/gfx360.
    [9] BERGER MF, BADELL IR. Single donor-derived pseudomonas aeruginosa pseudoaneurysms in two kidney transplant recipients: a case report of dichotomous allograft outcomes[J]. Transplant Proc, 2017, 49(10):2357-2361. DOI: 10.1016/j.transproceed.2017.10.015.
    [10] ZHEN W, YEYONG Q, BINGYI S, et al. Donor-derived renal mixed fungal infections in cardiac death donor kidney transplant recipients[J]. Nephrology (Carlton), 2017, 22(11):926. DOI: 10.1111/nep.12976.
    [11] BARNES JCH, GOODYEAR SJ, IMRAY CEA, et al. Kidney retransplantation from HLA-incompatible living donors: a single-center study of 3rd/4th transplants[J]. Clin Transplant, 2017, 31(11). DOI: 10.1111/ctr.13104.
    [12] GRAVES RC, FINE RN. Kidney retransplantation in children following rejection and recurrent disease[J]. Pediatr Nephrol, 2016, 31(12):2235-2247. doi: 10.1007/s00467-016-3346-0
    [13] CAILLARD S, CELLOT E, DANTAL J, et al. A french cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders[J]. Clin J Am Soc Nephrol, 2017, 12(10):1663-1670. DOI: 10.2215/CJN.03790417.
    [14] KAUSMAN JY, WALKER AM, CANTWELL LS, et al. Application of an epitope-based allocation system in pediatric kidney transplantation[J]. Pediatr Transplant, 2016, 20(7):931-938. DOI: 10.1111/petr.12815.
    [15] FERRARI P, CANTWELL L, TA J, et al. Providing better-matched donors for HLA mismatched compatible pairs through kidney paired donation[J]. Transplantation, 2017, 101(3):642-648. DOI: 10.1097/TP.0000000000001196.
    [16] SELLARÉS J, DE FREITAS DG, MENGEL M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence[J]. Am J Transplant, 2012, 12(2):388-399. DOI: 10.1111/j.1600-6143.2011.03840.x.
    [17] TAIT BD, SÜSAL C, GEBEL HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation[J]. Transplantation, 2013, 95(1):19-47. DOI: 10.1097/TP.0b013e31827a19cc.
    [18] WANG M, CLAESSON MH. Classification of human leukocyte antigen (HLA) supertypes[J]. Methods Mol Biol, 2014, 1184:309-317. DOI: 10.1007/978-1-4939-1115-8_17.
    [19] CAMPOS A, MALHEIRO J, TAFULO S, et al. Increase of allosensitization after a kidney graft failure: predictors and effect on retransplantation outcomes[J]. Nefrologia, 2017, 37(4):397-405. DOI: 10.1016/j.nefro.2016.11.020.
    [20] MARFO K, LU A, LING M, et al. Desensitization protocols and their outcome[J]. Clin J Am Soc Nephrol, 2011, 6(4):922-936. DOI: 10.2215/CJN.08140910.
    [21] 陈实.移植学[M].北京:人民卫生出版社, 2011:1965.
    [22] 陈实, 石炳毅.临床技术操作规范:器官移植分册[M].北京:人民军医出版社, 2010:137.
    [23] 夏穗生.中华器官移植医学[M].南京:江苏科学技术出版社, 2011:755.
    [24] LIM MA, KOHLI J, BLOOM RD. Immunosuppression for kidney transplantation: where are we now and where are we going?[J]. Transplant Rev (Orlando), 2017, 31(1):10-17. DOI: 10.1016/j.trre.2016.10.006.
  • 加载中
计量
  • 文章访问数:  249
  • HTML全文浏览量:  217
  • PDF下载量:  87
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-06-20
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2019-09-15

目录

    /

    返回文章
    返回